InvestorsHub Logo
Followers 29
Posts 118
Boards Moderated 0
Alias Born 07/29/2019

Re: Don'tDrinkTheKoolAid post# 11100

Sunday, 08/18/2019 2:05:46 AM

Sunday, August 18, 2019 2:05:46 AM

Post# of 54910

Stockboy,

I appreciate your timeline of an approved NASDAQ listed company.

Bradley Robinson, PRED's CEO was not interviewing with CNBC the day he visited with NASDAQ officials, there were other meetings with media and of institutional financial importance, some details of which I understand may soon become known from Predictive.
Bradley Robinson and others did meet with NASDAQ, after which he was shown where the listed companies "Ring the Bell". Again, his smile is apparent in the many photographs I personally took while officials were present.

The speculation and hype of an immediate listing from photographs are silly, and it suffices to say the company is executing its specific business plans as approved by its world-class Board and management team.

Even so, this and other messaging boards miss the fundamentals of the company, it’s disclosed and undisclosed IP and the global marquee fact that it is represented by one of the world's leading life science law firms - Wilson Sonsini Goodrich and Rosati (WSGR). More importantly one of WSGR's attorney sits on Predictive Advisory Board. Perhaps worth mention that prior to Google's IPO a WSGR attorney sat on Google's Advisory Board, and there are many others like situations for global companies.

See: https://www.wsgr.com/WSGR/Default.aspx

See WSGR's Summer 2019 global life science report here:

https://www.wsgr.com/publications/PDFSearch/life-sciences-report/Summer19/medical-device-biotechnology-companies.htm


See WSGR's Winter/Spring 2019 global life science report here:

https://www.wsgr.com/publications/PDFSearch/life-sciences-report/Winter19/medical-device-biotechnology-companies.htm

Hindenburg was pure market manipulation by "shorts consisting of a group of brokers" who committed civil (if not criminal) conspiracy and fraud. The company's attorneys are managing this matter while management focuses on its business, its customers, building its laboratories with the latest state of the art equipment, compliance, and regulatory teams. I have personally spoken with the SEC on this matter as well and will be meeting with SEC lead attorneys in the coming weeks.

I have it on good authority that the Preeclampsia Foundation did retain a well known outside law firm to investigate the allegations within the Hindenburg report - after which the same law firm concluded the Predictive and Preeclampsia relationship should proceed and a press announcement soon followed. Another outside law firm concluded the allegations were false.

From what I witnessed, and because I believe in facts rather than speculation, the company will be listed on NASDAQ. Neither anyone nor I know if that listing is imminent next week, the week after, etc. My best guess is sooner than later noting that the company has fully complied with the requirements to be listed, and will continue to do so.

More interestingly there are many self-appointed experts that have as of yet taken the time to read and understand the requirements to list on NASDAQ, nor appreciate the significant expense and commitment of internal and professional resources required to complete the listing requirements which Predictive has completed.

These same NASDAQ listing requirements follow in the link below, and if the Hindenburg allegations were true, Predictive and its representatives would not be in meetings with or at NASDAQ.

http://nasdaq.cchwallstreet.com/NASDAQTools/PlatformViewer.asp?selectednode=chp%5F1%5F1%5F4%5F4%5F8%5F3&manual=%2Fnasdaq%2Fmain%2Fnasdaq%2Dequityrules%2F

Again, we are not selling a single share and staying for the long term benefits of owning equity in what we believe will soon become a global therapeutics company with significant global revenue. This is not speculation but from a hard review of the facts and the team within Predictive.

Again, I comment that Bradly Robinson has not sold one share of PRED in the last two years, which is disclosed within the FORM 10 requirements.

No Predictive Officer or Director has requested, directed, or authorized me to provide commentary on this or other message boards. My motivation is truth and transparency so others are not subjected to past or other's false (self-interest) allegations that have resulted in financial harm to PRED's shareholders. I know the company's management and Board with whom I have spoken have expressed the same concerns in many conversations.

One of the last places market manipulators and criminals can freely operate is within the OTC by fabricating and misrepresenting facts to strike fear among small shareholders so they can, in fact, steal their money by fraud. A $1.2 billion hit on the market cap of Predictive has not gone unnoticed by the SEC and as I understand the FBI. The brokers who participated are known, as are the two national brokerages that participated through the same brokers. It appears therein may be substantial assets from which a shareholder's class of plaintiffs to recover losses.